Stock Price
141.15
Daily Change
0.49 0.35%
Monthly
-7.59%
Yearly
-43.01%
Q1 Forecast
138.07

CSL reported $37.9B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Arca Biopharma USD 509.25M 151.83M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Bio Path USD 746K 1.45M Jun/2025
Brainstorm Cell Therapeutics USD 1.38M 1.19M Sep/2025
Cara Therapeutics USD 43.75M 4.8M Jun/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 29.23M 10.09M Jun/2025
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024